ID

26173

Descrizione

Study ID: 100601 Clinical Study ID: LPL100601 Study Title: LPL100601, A Clinical Outcomes Study of Darapladib versus Placebo in Subjects with Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00799903 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: darapladib Trade Name: darapladib Study Indication: Atherosclerosis Study part: End of study Survival status

Keywords

  1. 10/10/17 10/10/17 -
  2. 16/10/17 16/10/17 -
  3. 23/10/17 23/10/17 -
  4. 11/01/18 11/01/18 -
Titolare del copyright

GlaxoSmithKline

Caricato su

10 ottobre 2017

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY-NC 3.0

Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

End of study Survival status GSK study Chronic Coronary Heart Disease NCT00799903

End of study Survival status GSK study Chronic Coronary Heart Disease NCT00799903

Assessment date
Descrizione

Assessment date

1. Most recent survival status assessment
Descrizione

Most recent survival status assessment

Tipo di dati

date

Survival data
Descrizione

Survival data

1. Subject status
Descrizione

Subject status

Tipo di dati

integer

If subject known to be alive: Subject known to be alive on (date)
Descrizione

Date Subject known to be alive

Tipo di dati

date

If subject known to be alive: Source of information
Descrizione

Subject alive Source of information

Tipo di dati

text

If subject known to be alive: Other source of information, specify
Descrizione

Subject alive Source of information specification

Tipo di dati

text

If subject died: date that site acquired death information
Descrizione

date that site acquired death information

Tipo di dati

date

If subject died: Source of information
Descrizione

death of subject Source of information

Tipo di dati

text

If subject died: Other source of information, specify
Descrizione

Subject dead Source of information specification

Tipo di dati

text

Similar models

End of study Survival status GSK study Chronic Coronary Heart Disease NCT00799903

Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
Assessment date
Most recent survival status assessment
Item
1. Most recent survival status assessment
date
Item Group
Survival data
Item
1. Subject status
integer
Code List
1. Subject status
CL Item
Subject known to be alive (1)
CL Item
Subject died (2)
Date Subject known to be alive
Item
If subject known to be alive: Subject known to be alive on (date)
date
Item
If subject known to be alive: Source of information
text
Code List
If subject known to be alive: Source of information
CL Item
Health care provider other than investigative site staff (1)
CL Item
Family member (2)
CL Item
Publicly available information (3)
CL Item
Other (OT)
CL Item
Investigative site staff (4)
CL Item
Friend or neighbor (5)
Item
If subject known to be alive: Other source of information, specify
text
Code List
If subject known to be alive: Other source of information, specify
date that site acquired death information
Item
If subject died: date that site acquired death information
date
Item
If subject died: Source of information
text
Code List
If subject died: Source of information
CL Item
Health care provider other than investigative site staff (1)
CL Item
Family member (2)
CL Item
Publicly available information (3)
CL Item
Other (OT)
CL Item
Investigative site staff (4)
CL Item
Friend or neighbor (5)
Subject dead Source of information specification
Item
If subject died: Other source of information, specify
text

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial